In the present study, we provide in silico evidence that NCL overexpression occurs in a broad spectrum of breast tumors, with a significant upregulation in the most aggressive forms of BC, such as TNBC, both at the RNA and protein level (Fig. 1 and S1). This evidence concerns the gene NUCLEOLIN and breast cancer.